Semiconductor-Powered Diagnostics
Novascope is a BioIC company — applying semiconductor engineering rigor to biomolecular detection. Every layer — chip, reader, cartridge, software, antibodies, surface chemistry — is designed, built, and owned by Novascope. Zero external silicon IP. Zero royalties. End-to-end.
Platform
NovaCHIPIn-House ASIC Design
3 chip series (NS01/NS02/NS03). UMC foundry. 2.4B sensors per biochip. 100% proprietary silicon IP — zero royalties.
NovaLINKPatented Surface Chemistry
Antifouling + high specificity. Flexible linker-probe pair. Core trade secret for manufacturing yield and femtogram sensitivity.
NovaBIOProprietary Bio-Probes
In-house buffer system, ZNA probes, VHH nanobodies & IgG mAbs. 10+ antibody families developed from animal to chip.
NovaKITAnalyzer & Cartridge
~200-component reader with in-house firmware. Disposable cartridge with microfluidics. Full software stack for hospital integration.
NovaAISignal Intelligence
Proprietary signal-to-noise algorithms at femtogram sensitivity. Smart manufacturing QC. AI-implemented automation.
NovaCROClinical Biobank & Lab
~100K bacterial isolates, 394 species. PET-validated AD samples. Certified contract lab for regulatory validation.
From Sample to Answer
Complete diagnostic workflow in under 60 minutes
Bare Chip
UMC CMOS fab
50K chips/lot
Bioprobe Binding
Surface chemistry links probes
Apply Sample
Blood or plasma specimen
Bio-Sensing
FET detects charge changes
Signal Reading
Digital readout via reader
NovaAI Result
AI-powered clinical output
Chip Portfolio
Six successful chip generations. Each manufactured at UMC. Each fully validated.
Precision FET Biosensor
High-precision FET for surface-charge detection. Up to 8 targets simultaneously. 3×3 mm die, 2.4 billion sensor sites. All current pipeline products built on NS01C.
Array Sensor
High-density array for scalable multiplexing across large biomarker panels. Suited for pathogen panels and AMR profiling.
Optoelectronic Sensor
Integrates FET + photodiode on single die — hybrid electrical-optical detection for expanded assay flexibility.
Unprecedented detection density: 2.4 billion sensors per biochip, 300M per sensing block (0.5 mm²), 4M per sensing unit (6 μm²).
Prototype Products
Ready for clinical validations and pilot manufacturing
NS01 BioChip Die
CMOS FET biosensor at UMC
Sample Preparation
Microfluidics-based handling
Disposable Cartridge
Single-use NovaCHIP cartridge
Portable Reader
Compact POC reader
Automated BioChip Platform
A complete IVD instrument designed in-house. ~200 components including touch panel, barcode scanner, motion control, and custom sensor PCB supporting 1–8 chips per run. Cross-platform verified against Quanterix SIMOA.
Intellectual Property
A walled garden: zero external IP dependencies, zero royalties
40+ Patents Filed Worldwide
IP spans chip architecture, sensing circuitry, surface chemistry, reagent systems, and integrated platforms.
End-to-End Ownership
Chip design, circuit layout, mask design, foundry validation. Reader hardware, firmware, protocols, software. Antibodies, nanobodies, probes, surface chemistry. Cartridge, microfluidics, sample prep. AI signal processing — all developed internally with full patent ownership.
The cleanest IP table in the diagnostic semiconductor space.
FET-Based Biosensor Competitive Landscape
| NanoDx | Paragraf | NOVASCOPE | |
|---|---|---|---|
| Founded | 2010 / US | 2017 / UK | 2022 / Taiwan |
| Device | Silicon nanowire FET | Monolayer graphene FET | Extended-gate FET (CMOS) |
| Challenge | Sensor reproducibility | Scalability, graphene uniformity | Clinical validation at scale |
| Production | In development | Pilot production | Pilot production |
| Cost/Test | Not yet available | $143 | COGS ~$10 |
| Capital Raised | $30M (Series C, 2020) | $85M (Series C, 2025) | $22.5M (Series A+B) |
Competitor data from publicly available sources, Q1 2026.